Reti-CVD

Biomarker

1 paper4 findings

In a human study using a hybrid care model, Reti-CVD is associated with hypertension, diabetes and PREVENT, and predicts PREVENT-defined risk thresholds. Agreement with PREVENT is κ = 0.144, with weighted κ = 0.241.

  • Humans1

Associations

4

PREVENT

upin humans1

1 study
  1. Reti-CVD is associated with PREVENT in humans (κ = 0.144; weighted κ = 0.241).

    Humanshybrid care modeln = 1,461

    AI-powered retinal imaging for early ASCVD risk stratification in a hybrid care model: preliminary findings from SAFER

    Frontiers in artificial intelligence3 Sep 2026

More on PREVENT

Diabetes

upin humans1

1 study
  1. Reti-CVD is associated with diabetes in humans (p < 0.001).

    Humanshybrid care modeln = 1,461

    AI-powered retinal imaging for early ASCVD risk stratification in a hybrid care model: preliminary findings from SAFER

    Frontiers in artificial intelligence3 Sep 2026

More on Diabetes

Hypertension

upin humans1

1 study
  1. Reti-CVD is associated with hypertension in humans (p < 0.001).

    Humanshybrid care modeln = 1,461

    AI-powered retinal imaging for early ASCVD risk stratification in a hybrid care model: preliminary findings from SAFER

    Frontiers in artificial intelligence3 Sep 2026

More on Hypertension

PREVENT-defined risk thresholds

upin humans1

1 study
  1. Reti-CVD predicts PREVENT-defined risk thresholds in humans (AUC 0.689-0.757).

    Humanshybrid care modeln = 1,461

    AI-powered retinal imaging for early ASCVD risk stratification in a hybrid care model: preliminary findings from SAFER

    Frontiers in artificial intelligence3 Sep 2026

More on PREVENT-defined risk thresholds

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 01 in 12 months